Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds HC Wainwright & Co. Reiterates Buy on Kinnate Biopharma, Maintains $33 Price Target

HC Wainwright & Co. Reiterates Buy on Kinnate Biopharma, Maintains $33 Price Target

HC Wainwright & Co. analyst Robert Burns reiterates Kinnate Biopharma (NASDAQ:KNTE) with a Buy and maintains $33 price target.

byBenzinga Newsdesk

March 20, 2023

1 minute read

HC Wainwright & Co. analyst Robert Burns reiterates Kinnate Biopharma (NASDAQ:KNTE) with a Buy and maintains $33 price target.

Analyst Ratings

Expert Ratings for Diamondback Energy

By Benzinga Insights

November 8, 1:45 PM

Diamondback Energy (NASDAQ:FANG) has observed the following analyst ratings within the last quarter:

FANG

Bilibili Clocks Healthy Q3 Revenue Growth, MPUs Jump 19%

By Anusuya Lahiri

November 29, 8:24 AM

Bilibili Inc (NASDAQ:BILI) reported third-quarter FY22 revenue growth of 11% year-on-year to $814.5 million (RMB5.8 billion), beating the consensus of…

BILI

Telsey Advisory Group Maintains Outperform on Grocery Outlet Holding, Raises Price Target to $50

By Benzinga Newsdesk

August 10, 5:51 AM

Telsey Advisory Group analyst Joseph Feldman maintains Grocery Outlet Holding (NASDAQ:GO) with a Outperform and raises the price target from $48 to $50.

How To Earn $500 A Month From United States Steel Stock Ahead Of Q4 Earnings Print

By Avi Kapoor

February 1, 9:22 AM

With the recent buzz around U.S. Steel Corporation (NYSE: X), some investors may be eyeing potential gains from the company’s dividends.

HC Wainwright & Co. Reiterates Buy on Kinnate Biopharma, Maintains $33 Price Target

Related Posts

Expert Ratings for Diamondback Energy

Bilibili Clocks Healthy Q3 Revenue Growth, MPUs Jump 19%

Telsey Advisory Group Maintains Outperform on Grocery Outlet Holding, Raises Price Target to $50

How To Earn $500 A Month From United States Steel Stock Ahead Of Q4 Earnings Print